Evidence map›Paper›PMID 41179735›Full record

ArticleWorld journal of hepatology2025

Novel educational video module about alcohol use disorder increases treatment rates and decreases return to alcohol use.

Patrick Twohig, Zachary P Slocum, Anna Willet, Makayla Schissel, Alëna A Balasanova, Kyle Scholten, Josh Warner, Tomoki Sempokuya, Nathalie Khoury, Allison Ashford and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Patrick TwohigDepartment of Gastroenterology and Hepatology, University of Rochester Medical Center, Rochester, NY 14682, United States. patrick_twohig@urmc.rochester.edu.
Zachary P SlocumDepartment of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, United States.
Anna WilletDepartment of Transplant Hepatology, Sanford Health, Sioux Falls, SD 57105, United States.
Makayla SchisselDepartment of Biostatistics, University of Nebraska Medical Center, Omaha, NE 68198, United States.
Alëna A BalasanovaDepartment of Psychiatry, University of Nebraska Medical Center, Omaha, NE 68198, United States.
Kyle ScholtenDepartment of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, United States.
Josh WarnerDepartment of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, NE 68198, United States.
Tomoki SempokuyaDivision of Gastroenterology and Hepatology, Department of Medicine, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, United States.
Nathalie KhouryDivision of Gastroenterology and Hepatology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, United States.
Allison AshfordDepartment of Medicine and Pediatrics, University of Nebraska Medical Center, Omaha, NE 68198, United States.
Thoetchai B PeeraphatditDepartment of Gastroenterology and Hepatology, Midwest Gastrointestinal Associates, Omaha, NE 68114, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients and providers are often unaware of available treatment options for alcohol use disorder (AUD) and how to pursue them.

aimTo improve AUD treatment rates using an educational video module (EVM).

methodsProspective single-center cohort study evaluating the impact of a novel interactive patient EVM in promoting AUD treatment among hospitalized patients with alcohol-associated liver disease. Treatment was defined as receiving medication or participating in psychosocial treatment within 30 days of discharge. Primary outcome was change in treatment rates after viewing the EVM compared to a retrospective control cohort. Secondary outcomes were predictors of receiving treatment, EVM feedback, 30-day hospital readmission, outpatient follow-up, return to alcohol use, and mortality.

resultsForty-two patients were included. Mean age was 45 years, 50% were female, and mean model for end-stage liver disease score 15.5. After viewing the EVM, treatment rates increased for pharmacologic (50%

conclusionEVM allows hospitalized patients to receive standardized education about AUD treatment. This may address patient and provider knowledge gaps and reduce the growing burden of alcohol-associated liver disease. Future studies should evaluate EVM in larger patient populations using a multi-center study design.

Indexed as

Addiction treatmentAlcohol-associated liver diseaseAlcohol use disorderHospital-based interventionPatient educationQuality improvementVideo

Identifiers

PMID41179735
PMCPMC12576702

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.